The Prognostic Significance of Multidrug Resistance-associated Protein 2 Expression in Primary Breast Carcinoma

王树滨,孙宇萍,刘雅洁,陈亦欣,徐敏,陈伟,隋广杰,杨纯正
DOI: https://doi.org/10.3969/j.issn.1671-5098.2006.13.001
2006-01-01
Abstract:Objective Intrinsic and/or acquired resistance was the major obstacle to overcome in the treatment of patients with breast cancer.The aim of the present study was to investigate the relationship between the expression of multidrug resistance-associated protein 2 (MRP2) with the clinicpathologic characteristics and the prognosis in primary breast cancer patients.Methods Expression of MRP2 in 47 breast cancer patients was determined by immunohistochemistry on formalin-fixed,paraffin-embedded tumor section.Results MRP2 expression was observed in 40 of 47(85.1%).No relation can be established between expression of MRP2 and other clinicopathologic parameters.Kaplan-Meier analyses revealed that MRP2 expression didn't associated with disease-free survival (DFS) or overall survival (OS) (P>0.05).In multivariate Cox regression analysis,tumor size and lymph node metastasis was independent prognostic factors for survival (P<0.05).Conclusion Our results suggested that MRP2 is frequently expression in primary breast cancer,but MRP2 is not a poor prognostic factor in patients with breast cancer.
What problem does this paper attempt to address?